In documents released leading up to the panel meeting, the FDA itself expressed that the evaluation criteria weigh against broadening the compounding of experimental drugs like BPC-157, citing limited evidence for unapproved peptides and the availability of currently approved medications with actual research support behind them.7 Medical practitioners are quick to emphasize what is still unknown
Transportation also matters
Yes, a deficiency can lead to a state of hyper-arousal in the nervous system, which is a leading cause of both sleep onset insomnia and increased evening anxiety.
Exists as reduced (GSH) and oxidized (GSSG, disulfide dimer) forms
Here, the peptide might indeed have beneficial effects for joint pain relief, mainly due to the following (potential) effects: BPC-157 is claimed to have anti-oxidant properties and lend to advanced tissue support for bones and muscles
Kate Lyzenga-Dean , an expert in Integrative and Functional Medicine with over a decade of experience, understands this challenge intimately